Clinical Trial Update: Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer [NA]

View source ↗

Summary

Completed Phase I/II trial evaluating carbon ion radiotherapy for recurrent rectal cancer at University Hospital Heidelberg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Carbon ion radiotherapy (carbon ion radiotherapy)

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Recurrent Rectal Cancer | NA | Status: COMPLETED